← Back to Search

Time Restricted Eating for Obesity

N/A
Waitlist Available
Led By Bradley Bohn, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks
Awards & highlights

Study Summary

This trial looks at the effects of when you eat on weight and BMI, and how it affects quality of life.

Who is the study for?
This trial is for obese adults with a BMI of 25 or higher who are willing to limit their eating to an 8-hour window. It's not suitable for those with cancer, pregnant or breastfeeding women, individuals who regularly skip meals, those on certain diabetes or weight loss medications, and people with a history of eating disorders.Check my eligibility
What is being tested?
The study is examining the effects of early versus late time-restricted eating on weight and BMI in obese adults. Participants will be asked to eat only during an 8-hour period each day to see how this impacts their health and quality of life.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include hunger outside the eating window, potential changes in energy levels, mood swings due to hunger pangs, and possible alterations in social meal times.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in weight
Secondary outcome measures
Change in Hemoglobin A1c
Change in High-density lipoprotein (HDL) cholesterol
Change in Low-density lipoprotein (LDL) cholesterol
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Late time-restricted eatingExperimental Treatment1 Intervention
Subjects window for eating would be between 12:00 PM (noon) and 8:00 PM
Group II: Early time-restricted eatingExperimental Treatment1 Intervention
Subjects window for eating would be between 08:00 AM - 4:00 PM
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Late time-restricted eating
2022
N/A
~200
Early time-restricted eating
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,684 Total Patients Enrolled
85 Trials studying Obesity
14,723 Patients Enrolled for Obesity
Bradley Bohn, MDPrincipal InvestigatorMayo Clinic

Media Library

Early time-restricted eating Clinical Trial Eligibility Overview. Trial Name: NCT05660291 — N/A
Obesity Research Study Groups: Late time-restricted eating, Early time-restricted eating
Obesity Clinical Trial 2023: Early time-restricted eating Highlights & Side Effects. Trial Name: NCT05660291 — N/A
Early time-restricted eating 2023 Treatment Timeline for Medical Study. Trial Name: NCT05660291 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I participate in this clinical investigation?

"The trial is recruiting a cohort of 100 individuals with overweight, whose age falls between 18-64. The most essential requirement for enrollment is that the patients' BMI should be equal or greater than 25."

Answered by AI

Are octogenarians being sought after to participate in this scientific research?

"The study's criteria specifies that qualified applicants must be between 18 and 64 years old. Furthermore, there are 55 trials for those under 18 and 207 studies catering to patients above 65."

Answered by AI

Is the recruitment for this research active at the moment?

"According to clinicaltrials.gov, the trial is no longer recruiting participants. It was initially listed on January 1st 2023 and most recently updated on December 13th 2022. Despite its conclusion, there are still 338 other trials actively searching for patients at this time."

Answered by AI
~33 spots leftby Dec 2024